[Diagnosis by recombinant DNA techniques and clinical features of familial amyloid polyneuropathy]
1Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
Abstract:
Serum prealbumin variant with a substitution of methionine (Met) for valine (Val) at position 30 is known to be related to Andrade type familial amyloid polyneuropathy (FAP). Recently, the diagnosis of FAP by recombinant DNA techniques has been established. The DNA diagnosis is based on the fact that a nucleotide substitution responsible for Val-Met change results in formation of new restriction sites for Nsi 1 and Bal 1. We conducted the DNA diagnosis studies of 30 constituents of FAP pedigrees originated from Nagano and Hiroshima Prefectures, and compared the results with clinical features. Clinical features of the patients originated from Ogawa Village area in Nagano Prefecture and from Hiroshima Prefecture showed Andrade type FAP such as polyneuropathy and autonomic nervous disorders. Those of the patients from Iiyama City in Nagano Prefecture showed central nervous involvement such as cerebellar ataxia and/or pyramidal tract signs in addition to the clinical features of Andrade type FAP (Iiyama type). DNA prepared from white blood cells was digested with restriction endonuclease Nsi 1 or Bal 1 and subjected to Southern blot hybridization. The resulting DNA segments were fractionated by agarose gel electrophoresis. The gel was alkalized to convert the double-strand DNA to a single-strand form, which then was absorbed on a nylon membrane filter. The prealbumin cDNA was labelled with 32P as a probe. The probe was hybridized with DNA segments on a filter. The filter was placed on the X-ray film to obtain the autoradiogram.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Familial amyloid polyneuropathy (FAP) diagnosis is advanced by DNA testing, identifying a specific prealbumin variant linked to Andrade type FAP. This genetic analysis correlates with distinct clinical presentations in Japanese pedigrees.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Context:
- Familial amyloid polyneuropathy (FAP) is a hereditary disorder.
- A specific prealbumin variant (Val30Met) is associated with Andrade type FAP.
- Recombinant DNA techniques offer new diagnostic possibilities.
Purpose:
- To conduct DNA diagnosis for familial amyloid polyneuropathy (FAP) in Japanese pedigrees.
- To correlate genetic findings with clinical manifestations.
- To investigate the utility of restriction fragment length polymorphism (RFLP) analysis for FAP diagnosis.
Summary:
- DNA diagnosis was performed on 30 individuals from FAP pedigrees in Nagano and Hiroshima Prefectures.
- The study identified a prealbumin variant (Val30Met) using Nsi 1 and Bal 1 restriction enzymes.
- Clinical features were compared with genetic findings, distinguishing between Andrade type FAP and a variant observed in Iiyama City (Iiyama type FAP).
Impact:
- Establishes a DNA-based diagnostic method for FAP.
- Differentiates clinical subtypes of FAP based on genetic markers.
- Provides insights into the genetic basis and clinical heterogeneity of FAP in Japan.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Alzheimer Disease l: Introduction
Huntington Disease l: Introduction


